Attendees at PDA's conferences can expect the participation of global regulators, either as speakers, audience attendees and/or as members of the planning committees for the event. Hot regulatory topics are always addressed at the PDA/FDA Joint Regulatory Conference, but more focused discussion of regulatory topics will occur at the Pharmaceutical Metrics and Quality Culture Conference (Feb. 21-22, Bethesda, Md.), Annex 1 Workshop (May 10-11, Washington), Biosimilars Conference (Jun. 26-27, Bethesda, Md.), and the Post-Approval Change Innovation for Availability of Medicines Workshop (Sept. 13-14, Washington).
The full schedule of 2017 PDA Conferences can be found here. Members of the press may request Press Passes here.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pda-unveils-2017-global-conference-schedule-300380002.html
SOURCE Parenteral Drug Association